Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 01:30:03 12/08/2026 am IST			5-day change	1st Jan Change
282.00 ^USD	+1.81%		+20.45%	+41.37%

10/08	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT
10/08	Rothschild & Co Redburn Adjusts PT on Charles River Laboratories International to $318 From $241, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,462	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	34.31%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	15,575	15,093	14,700
Change	-	-36.28%	7.39%	-20.91%	3.29%	30.38%	-3.09%	-2.61%
P/E	49.4x	23.1x	25.9x	931x	-70x	75.5x	30.2x	27x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.47x	3.8x	3.38x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	2.3x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.44x	3.36x	3.2x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.98x	3.77x	3.49x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.4x	13.8x	12.5x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	19x	16.5x	14.7x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	49.3x	24.8x	30.8x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.03%	4.04%	3.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.738	9.346	10.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,911	4,001	4,208
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,008	1,093	1,174
EBIT ¹	742.1	834	838.8	805.9	793.9	821	912.3	1,001
Net income ¹	391	486.2	474.6	10.3	-144.3	162.5	427.8	471.2
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,631	1,237
Reference price ²	375.34	218.92	238.84	186.16	203.66	282.00	282.00	282.00
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	75.45x	3.98x	15.45x	-.--%	1.35TCr
LONZA GROUP AG	33.79x	6.03x	17.93x	0.95%	4.95TCr
REVOLUTION MEDICINES, INC.	-21.33x	304.18x	-21.64x	-.--%	4.41TCr
BEONE MEDICINES AG	47.52x	5.43x	29.85x	-.--%	4.08TCr
IQVIA HOLDINGS INC.	31.4x	3.1x	13.37x	-.--%	4.01TCr
CELLTRION, INC.	32.03x	9.22x	23.17x	0.36%	3.42TCr
MEDPACE HOLDINGS, INC.	34.43x	5.65x	25.65x	-.--%	1.69TCr
EUROFINS SCIENTIFIC SE	23.25x	2.04x	8.83x	1.16%	1.4TCr
ICON PUBLIC LIMITED COMPANY	28.05x	1.88x	11.54x	-.--%	1.28TCr
Average	31.62x	37.95x	13.79x	0.27%	2.95TCr
Weighted average by Cap.	27.50x	54.77x	12.77x	0.28%